GLOBAL CRISPR MARKET 2019-2028

Lifesciences | Diagnostic & Biotechnology

GLOBAL CRISPR MARKET 2019-2028

Market By Product, Application And End-user | Forecast 2019-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The detailed analysis of the global CRISPR market shows that in terms of revenue, the industry is estimated to grow at a CAGR of 23.95% during the forecasting years 2019-2028. The market that was valued at $850.1 million in 2019, is predicted to reach $5872.4 million by the year 2028.

The chief factor enhancing the CRISPR (Clustered Regularly Interspaced Short Palindrome Repeats) market is the growing incidence of genetic ailments. Several start-ups and research firms have emerged in recent years. As per an article, the US Food and Drug Administration (FDA) has approved to perform a coronavirus test with the help of gene-editing technology CRISPR.



We provide additional customization based on your specific requirements. Request For Customization

Scientists reported that roughly 20 human trials highlighting CRISPR are now in progress or soon will be hurled out. While the act of eradicating cells from the body, editing them and substituting them to help cure a patient is a productive pursuit, the ability to edit cells inside the body will open up the entire realm of human diseases to treatment and even eradication.

The study aims to get an overview of the CRISPR market in terms of various factors. Within this report, the key insights and the market definition regarding the CRISPR industry have been discussed. Also, regulatory outlook, value chain outlook, supply chain outlook, Porter’s five forces model and market attractiveness index have been studied in detail.

The growing lifestyle-oriented diseases, surging prevalence of genetic diseases, increasing application of drugs, rising aging population and incidence of genetic ailments are the drivers of the CRISPR market. However, the industry is facing market restraints like ethical and social issues associated with the technology and changing regulatory environment, which are obstructing the industry growth. Key opportunities like increased demand for CRISPR technology and advancements in the applications of gene-based therapy can be leveraged by the industry to gain the expected growth. However, challenges like alternate technologies and lack of awareness regarding the CRISPR technology are being faced by this market.




Geographies covered in the CRISPR market by region are:

           North America: The United States and Canada

           Europe: Germany, The United Kingdom, Spain, Italy, Russia, France and Rest of Europe

           Latin America: Mexico, Brazil and Rest of Latin America

           The Asia-Pacific: Japan, China, India, South Korea, ASEAN countries, New Zealand & Australia and Rest of Asia-Pacific

           The Middle East and Africa: Saudi Arabia, Turkey, South Africa, the United Arab Emirates and Rest of Middle East & Africa

The CRISPR market has been segmented as follows:

           By Product

o          Plasmids

o          Vectors

o          Proteins

           CAS 9

           CPF1

           Other Proteins

o          Designing Tools

o          gRNA

o          Control Kits

o          Library

o          Other Products

           By Application

o          Genetic Engineering/Genome Editing

           Genetically Modified Organisms

           Agricultural Biotechnology

           Other Genome Editing/Genetic Engineering

o          CRISPR Plasmid

o          gRNA Database/Gene Library

o          Human Stem Cells

o          Cell Line Engineering

           By End-user

o          Therapeutics and Drug Discovery

o          Biological Research

o          Agricultural Biotech

o          Industrial Biotech

The key players engaged in the CRISPR market are Integrated DNA Technologies Inc, Genedata AG, Transposagen Bio (Hera BioLabs), Cellectis, Thermo Fisher Scientific Inc, Lonza, GeneCopoeia Inc, Precision Biosciences, CRISPR Therapeutics, Addgene, Horizon Discovery Ltd, New England Biolabs, Applied StemCell, GenScript, DiaCarta, Sangamo Therapeutics, Intellia Therapeutics Inc, Editas Medicine, Sigma-Aldrich (Merck KGaA), Caribou Biosciences Inc and Origene Technologies Inc.

The strategic analysis for each of these companies has been covered in detail. The CRISPR market by company profile helps to dive into the data about the key market players in this industry.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL CRISPR MARKET – SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTE PRODUCTS

2.2.3.   BARGAINING POWER OF BUYERS

2.2.4.   BARGAINING POWER OF SUPPLIERS

2.2.5.   COMPETITIVE RIVALRY

2.3. REGULATORY OUTLOOK

2.4. VALUE CHAIN OUTLOOK

2.5. SUPPLY CHAIN OUTLOOK

2.6. TIMELINE OF GLOBAL CRISPR MARKET

2.7. PARENT MARKET OUTLOOK

2.8. KEY INSIGHT

2.9. MARKET ATTRACTIVENESS INDEX

2.10. MARKET DRIVERS

2.10.1.  GROWING LIFESTYLE-ORIENTED DISEASES

2.10.2.   URGING PREVALENCE OF GENETIC DISEASES

2.10.3.  INCREASING APPLICATION OF DRUGS

2.10.4.    RISING AGING POPULATION

2.10.5.   INCIDENCE OF GENETIC AILMENTS

2.11. MARKET RESTRAINTS

2.11.1. ETHICAL AND SOCIAL ISSUES ASSOCIATED WITH CRISPR TECHNOLOGY

2.11.2. CHANGING REGULATORY ENVIRONMENT

2.12. MARKET OPPORTUNITIES

2.12.1. INCREASED DEMAND FOR CRISPR  

2.12.2.  ADVANCEMENTS IN THE APPLICATIONS OF GENE-BASED THERAPY

2.13. MARKET CHALLENGES

2.13.1. ALTERNATIVE TECHNOLOGIES

2.13.2. LACK OF AWARENESS REGARDING THE TECHNOLOGY

3.    CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.3.1.   CAS 9

3.3.2.   CPF1

3.3.3.   OTHER PROTEINS

3.4. DESIGN TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4.    CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/ GENETIC ENGINEERING

4.1.1.   GENETICALLY MODIFIED ORGANISMS

4.1.2.   AGRICULTURAL BIOTECHNOLOGY

4.1.3.   OTHER GENOME EDITING/ GENETIC ENGINEERING

4.2. GRNA DATABASE/GENE LIBRARY

4.3. CRISPR PLASMID

4.4. HUMAN STEM CELLS

4.5. CELL LINE ENGINEERING

5.    CRISPR MARKET OUTLOOK - BY END-USER

5.1. THERAPEUTICS AND DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6.    CRISPR MARKET – REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   MARKET BY PRODUCT

6.1.2.   MARKET BY APPLICATION

6.1.3.   MARKET BY END-USER

6.1.4.   COUNTRY OUTLOOK

6.1.4.1.      THE UNITED STATES

6.1.4.2.      CANADA

6.2. EUROPE

6.2.1.   MARKET BY PRODUCT

6.2.2.   MARKET BY APPLICATION

6.2.3.   MARKET BY END-USER

6.2.4.   COUNTRY OUTLOOK

6.2.4.1.      THE UNITED KINGDOM

6.2.4.2.      FRANCE

6.2.4.3.      GERMANY

6.2.4.4.      SPAIN

6.2.4.5.      ITALY

6.2.4.6.      RUSSIA

6.2.4.7.      REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   MARKET BY PRODUCT

6.3.2.   MARKET BY APPLICATION

6.3.3.   MARKET BY END-USER

6.3.4.   COUNTRY OUTLOOK

6.3.4.1.      INDIA

6.3.4.2.      CHINA

6.3.4.3.      JAPAN

6.3.4.4.      SOUTH KOREA

6.3.4.5.      AUSTRALIA & NEW ZEALAND

6.3.4.6.      ASEAN COUNTRIES

6.3.4.7.      REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.   MARKET BY PRODUCT

6.4.2.   MARKET BY APPLICATION

6.4.3.   MARKET BY END-USER

6.4.4.   COUNTRY OUTLOOK

6.4.4.1.      BRAZIL

6.4.4.2.      MEXICO

6.4.4.3.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY PRODUCT

6.5.2.   MARKET BY APPLICATION

6.5.3.   MARKET BY END-USER

6.5.4.   COUNTRY OUTLOOK

6.5.4.1.      SAUDI ARABIA

6.5.4.2.      TURKEY

6.5.4.3.      UNITED ARAB EMIRATES

6.5.4.4.      SOUTH AFRICA

6.5.4.5.      REST OF MIDDLE EAST & AFRICA

7.    COMPANY PROFILE

7.1. ADDGENE

7.2. APPLIED STEMCELL

7.3. CARIBOU BIOSCIENCES INC

7.4. CELLECTIS

7.5. CRISPR THERAPEUTICS

7.6. DIACARTA

7.7. EDITAS MEDICINE

7.8. GENECOPOEIA INC

7.9. GENEDATA AG

7.10. GENSCRIPT

7.11. HORIZON DISCOVERY LTD

7.12. INTEGRATED DNA TECHNOLOGIES INC

7.13. INTELLIA THERAPEUTICS INC

7.14. LONZA 

7.15. NEW ENGLAND BIOLABS 

7.16. ORIGENE TECHNOLOGIES INC

7.17. PRECISION BIOSCIENCES

7.18. SANGAMO THERAPEUTICS

7.19. SIGMA-ALDRICH (MERCK KGAA)

7.20. THERMO FISHER SCIENTIFIC INC

7.21. TRANSPOSAGEN BIO (HERA BIOLABS)

8.    RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1.   OBJECTIVES OF STUDY

8.1.2.   SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1.   PRIMARY DATA SOURCES

8.2.2.   SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1.   EVALUATION OF PROPOSED MARKET

8.3.2.   IDENTIFICATION OF DATA SOURCES

8.3.3.   ASSESSMENT OF MARKET DETERMINANTS

8.3.4.   DATA COLLECTION

8.3.5.   DATA VALIDATION & ANALYSIS

List of table

TABLE 1        GLOBAL CRISPR MARKET BY REGION, 2019-2028 ($ MILLION)

TABLE 2        CHIEF CONCERNS RELATED TO GENETIC ENGINEERING

TABLE 3        GLOBAL CRISPR MARKET BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 4        GLOBAL PROTEINS MARKET BY TYPE, 2019-2028 ($ MILLION)

TABLE 5        TOOL NAMES AND THEIR PROVIDERS

TABLE 6        GLOBAL CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 7        GLOBAL GENOME EDITING/GENETIC ENGINEERING MARKET, BY TYPES, 2019-2028 ($ MILLION)

TABLE 8        BARRIERS TO ENTRY IN THE AGRICULTURAL SEED MARKET

TABLE 9        AGRICULTURE BIOTECH TRAITS INDUSTRY

TABLE 10      GLOBAL CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 11      GLOBAL CRISPR MARKET, BY REGION, 2019-2028 ($ MILLION)

TABLE 12      NORTH AMERICA CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 13      NORTH AMERICA CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 14      NORTH AMERICA CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 15      NORTH AMERICA CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 16      GM CROPS GROWN IN CANADA

TABLE 17      EUROPE CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 18      EUROPE CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 19      EUROPE CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 20      EUROPE CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 21      ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 22      ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 23      ASIA-PACIFIC CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 24      ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 25      LATIN AMERICA CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 26      LATIN AMERICA CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 27      LATIN AMERICA CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 28      LATIN AMERICA CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)

TABLE 29      MIDDLE EAST AND AFRICA CRISPR MARKET, BY PRODUCT, 2019-2028 ($ MILLION)

TABLE 30      MIDDLE EAST AND AFRICA CRISPR MARKET, BY APPLICATION, 2019-2028 ($ MILLION)

TABLE 31      MIDDLE EAST AND AFRICA CRISPR MARKET, BY END-USER, 2019-2028 ($ MILLION)

TABLE 32      MIDDLE EAST AND AFRICA CRISPR MARKET, BY COUNTRY, 2019-2028 ($ MILLION)      

List of Figures

FIGURE 1      GLOBAL CRISPR MARKET, BY REGION, 2019-2028 ($ MILLION)

FIGURE 2      VALUE CHAIN ANALYSIS

FIGURE 3      GLOBAL CRISPR MARKET, BY PLASMIDS, 2019-2028 ($ MILLION)

FIGURE 4      GLOBAL CRISPR MARKET, BY VECTORS, 2019-2028 ($ MILLION)

FIGURE 5      GLOBAL CRISPR MARKET, BY PROTEINS, 2019-2028 ($ MILLION)

FIGURE 6      GLOBAL PROTEINS MARKET, BY CAS 9, 2019-2028 ($ MILLION)

FIGURE 7      GLOBAL PROTEINS MARKET, BY CPF1, 2019-2028 ($ MILLION)

FIGURE 8      GLOBAL PROTEINS MARKET, BY OTHER PROTEIN, 2019-2028 ($ MILLION)

FIGURE 9      GLOBAL CRISPR MARKET, BY DESIGN TOOLS, 2019-2028 ($ MILLION)

FIGURE 10   GLOBAL CRISPR MARKET, BY GRNA, 2019-2028 ($ MILLION)

FIGURE 11   GLOBAL CRISPR MARKET, BY CONTROL KITS, 2019-2028 ($ MILLION)

FIGURE 12   GLOBAL CRISPR MARKET, BY LIBRARY, 2019-2028 ($ MILLION)

FIGURE 13   GLOBAL CRISPR MARKET, BY OTHER PRODUCTS, 2019-2028 ($ MILLION)

FIGURE 14   GLOBAL CRISPR MARKET, BY GENOME EDITING/ GENETIC ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 15   GLOBAL GENOME EDITING/ GENETIC ENGINEERING MARKET, BY GENETICALLY MODIFIED ORGANISMS/CROPS, 2019-2028 ($ MILLION)

FIGURE 16   GLOBAL GENOME EDITING/ GENETIC ENGINEERING MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2028 ($ MILLION)

FIGURE 17   GLOBAL GENOME EDITING/ GENETIC ENGINEERING MARKET, BY OTHER GENOME EDITING/ GENETIC ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 18   GLOBAL CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2019-2028 ($ MILLION)

FIGURE 19   GLOBAL CRISPR MARKET, BY CRISPR PLASMID, 2019-2028 ($ MILLION)

FIGURE 20   GLOBAL CRISPR MARKET, BY HUMAN STEM CELLS, 2019-2028 ($ MILLION)

FIGURE 21   GLOBAL CRISPR MARKET, BY CELL LINE ENGINEERING, 2019-2028 ($ MILLION)

FIGURE 22   GLOBAL CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2019-2028 ($ MILLION)

FIGURE 23   GLOBAL CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2019-2028 ($ MILLION)

FIGURE 24   GLOBAL CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 25   GLOBAL CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2019-2028 ($ MILLION)

FIGURE 26   NORTH AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 27   ADOPTION OF GMO CROPS IN THE US IN 2017 (%)

FIGURE 28   THE UNITED STATES CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 29   REASONS FOR ADOPTING GENETICALLY ENGINEERED CROP (BT COTTON)

FIGURE 30   GM CROPS GROWN IN CANADA

FIGURE 31   CANADA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 32   EUROPE CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 33   THE UNITED KINGDOM CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 34   FRANCE CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 35   GERMANY CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 36   SPAIN CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 37   ITALY CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 38   RUSSIA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 39   REST OF EUROPE CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 40   INDIA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 41   CHINA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 42   JAPAN CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 43   SOUTH KOREA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 44   AUSTRALIA & NEW ZEALAND CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 45   ASEAN COUNTRIES CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 46   REST OF ASIA-PACIFIC CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 47   BRAZIL CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 48   MEXICO CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 49   REST OF LATIN AMERICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 50   SAUDI ARABIA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 51   TURKEY CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 52   UNITED ARAB EMIRATES CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 53   SOUTH AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)

FIGURE 54   REST OF MIDDLE EAST & AFRICA CRISPR MARKET, 2019-2028 ($ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;